Inactive Instrument

iQX Limited

IQX

AU000000IQX4

1,600,000 shares of IQX Limited's Ordinary Shares are subject to a Lock-Up Agreement Ending on 8-JAN-2016.

January 07, 2016

1,600,000 shares of IQX Limited's Ordinary Shares are subject to a Lock-Up Agreement Ending on 8-JAN-2016. These shares will be under lockup for 760 days starting from 9-DEC-2013 to 8-JAN-2016.

Latest news about iQX Limited

IQX Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-09-09	CI
Iqx Limited Reports Earnings Results for the Half Year Ended December 31, 2020	21-03-09	CI
Iqx Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-09-11	CI
Iqx Limited Reports Earnings Results for the Half Year Ended December 31, 2019	20-03-15	CI
Iqx Limited Reports Earnings Results for the Full Year Ended June 30, 2019	19-09-16	CI
IQX Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2018	19-03-18	CI
IQX Limited announced that it has received AUD 1.244243 million in funding	19-01-14	CI
IQX Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2018	18-09-29	CI
IQX Limited Reports Unaudited Consolidated Earnings Results for the Year Ended June 30, 2018	18-09-14	CI
IQX Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2017	18-03-16	CI
IQX Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2017	17-10-19	CI
IQX Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2016	17-03-16	CI
1,600,000 shares of IQX Limited's Ordinary Shares are subject to a Lock-Up Agreement Ending on 8-JAN-2016.	16-01-07	CI
76,250,000 shares of IQX Limited's Ordinary Shares are subject to a Lock-Up Agreement Ending on 8-JAN-2015.	15-01-07	CI
IQX Limited announced that it expects to receive AUD 3 million in funding.	14-12-17	CI
IQX Limited has completed an IPO in the amount of AUD 4.15 million.	13-12-09	CI
IQX Limited has filed an IPO in the amount of AUD 6.50 million.	13-09-06	CI
IQX Limited has withdrawn its IPO in the amount of AUD 6.34 million.	13-09-03	CI

IQX Limited is an Australia-based investment funds management company specializing in the bioscience sector. The Company operates through two operating segments, financial services and office and shared services. The Company is engaged in investment activities and exploring investment opportunities primarily in Australian biotech and life science companies and other registered intellectual property. It is also engaged in underwriting primary and secondary capital raisings, and managing discretionary accounts. The Company's subsidiaries include iQX Capital Pty Ltd, iQX Investment Services Pty Ltd, Life Science Holdings Pty Ltd, iQ Capital Partners (No.1) Pty Ltd, iQ Series 8 Life Science (Global) LP, Neutron Investment Group Pty Ltd, Life Science Ventures (No.1) Pty Ltd, Prosoma Therapeutics (No.1) Pty Ltd, Prosoma Therapeutics (No.2) Pty Ltd, Prosoma Therapeutics (No.3) Pty Ltd, Prosoma Therapeutics (No.4) Pty Ltd, and Prosoma Therapeutics (No.5) Pty Ltd.

Sector

More about the company

iQX Limited

Equities

IQX

AU000000IQX4

1,600,000 shares of IQX Limited's Ordinary Shares are subject to a Lock-Up Agreement Ending on 8-JAN-2016.

Latest news about iQX Limited

Chart iQX Limited

Company Profile